Skip to main content
Offcanvas
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

 

The Syneos Health Insights Hub generates future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment.

  • Commercialization

2026 Dealmakers' Intentions Survey

Feb 18, 2026

Learn more about the expectations of biopharma decision makers in this forward-looking assessment of dealmaking activity for the year ahead.
  • CNS/Neuroscience

Rewriting the Rules of Psychiatry Drug Development: Measurement, Psychedelics and the Future of CNS Strategy

Mar 05, 2026

Explore how measurement innovation, psychedelic development and value strategy are reshaping psychiatric drug development and CNS clinical trials.

Download Now
  • Commercialization

The Syneos Health Podcast | Conversations on Commercialization

Feb 19, 2026

A limited series unpacking how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  
  • Commercialization

More Patients, Fewer Resources: The New Math of Patient Support

Apr 03, 2026

This white paper from Syneos Health explores how digital-first design, AI and smart-sourcing can help organizations build more scalable, efficient and patient-centric support...
  • Clinical Trial Acceleration

Rewriting the Rules: What the 2025 SyncUp Summit Signals for Clinical Development

Mar 18, 2026

Explore key insights from the 2025 SyncUp Summit from Syneos Health, including protocol design trends, enrollment strategy, AI integration and leadership development shaping...
  • Oncology

MRD as a Development Strategy: The Paradigm Shift Reshaping Oncology Trial Design

Mar 17, 2026

Explore how minimal residual disease (MRD) is evolving from prognostic marker to intervention trigger across oncology and what it means for trial design.
  • Real World Evidence

Turning Open-Label Extensions into Engines of Real World Evidence

Mar 13, 2026

Explore four key principles for transforming open-label extension studies (OLEs) into a strategic connector of real world evidence across the development lifecycle.
  • Commercialization

WEBINAR | The ART of Japanese Market Entry: Navigating Japan's Pharmaceutical Landscape

Mar 09, 2026

our Japan-based experts introduce the ART framework—Asset, Resource and Timeline—a practical lens for planning and executing a successful Japan market entry strategy.
  • CNS/Neuroscience

Rewriting the Rules of Psychiatry Drug Development: Measurement, Psychedelics and the Future of CNS Strategy

Mar 05, 2026

Explore how measurement innovation, psychedelic development and value strategy are reshaping psychiatric drug development and CNS clinical trials.
Interested in Syneos Health®?